Advertisement

Immunological Control of EBV Infected B Cells

  • Eva Klein
  • George Klein
Part of the NATO Advanced Science Institutes Series book series (NSSA, volume 57)

Abstract

The majority of individuals harbors EB-virus infected B cells (BEBV), (For characteristics of the virus-cell and virus host relationship see references 1 and 2). When blood lymphocytes or tissues from donors who experienced virus infection are explanted, the BEBV cells grow and can be easily established as permanent lines — LCLEBV, lymphoblastoid cell lines. Limiting dilution experiments estimated 500–5,000 B cells with proliferative potential in the blood. In acute IM (infectious mononucleosis) the number is higher and cells that carry the viral genome and consequently express a nuclear antigen, EBNA, can be visually detected in the isolated B subset. Robinson et al. showed that these cells divide.3 In fatal IM cases EBNA positive cells were detected also in the spleen, liver and thymus.

Keywords

Infectious Mononucleosis Immunological Control Viral Cycle Autologous Mixed Lymphocyte Reaction Host Range Mutant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    The Epstein-Barr virus, M.G. Epstein and B.G. Achong, Eds., Springer Yerlag, Berlin, Heidelberg, New York (1979).Google Scholar
  2. 2.
    Viral Oncology, G. Klein, ed., Raven Press, New York (1980).Google Scholar
  3. 3.
    J. Robinson, D. Smith, and J. Niederman, Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis. Nature 287: 334 (1980).CrossRefGoogle Scholar
  4. 4.
    D.T. Purtilo, D. Be Floria, L.M. Hutt, J. Bhawan, J.P.S. Yang, R. Otto, and W. Edwards, Variable phenotypic expression of an X-linked recessive lymph proliferative syndrome. New Engl. J. Med. 297: 1077 (1977).CrossRefGoogle Scholar
  5. 5.
    D. Volsky, G. Klein, B. Volsky, and I. Shapiro, Production of infectious Epstein-Barr virus in mouse lymphocytes. Nature 293: 399 (1981).CrossRefGoogle Scholar
  6. 6.
    W. Henle, and G. Henle, Epstein-Barr specific serology in immunologically compromised individuals. Cancer Res., in press.Google Scholar
  7. 7.
    M. Patarroyo, B. Blazar, G., Pearson, E. Klein, and G. Klein, Induction of the EBV cycle in B-lymphocyte- derived lines is accompanied by increased natural killer (NK) sensitivity and the expression of EBV-related antigen(s) detected by the ADCC reaction. Int. J, Cancer 26: 365 (1980).CrossRefGoogle Scholar
  8. 8.
    P. Gergely, I. Ernberg, G. Klein, and M. Steinitz, Blastogenic responses of purified human T-lymphocyte populations to Epstein-Barr virus (EBV). Clin. Exp, Immunol, 30: 347 (1977).Google Scholar
  9. 9.
    L.M. Hutt-Eletcher, and C.J. Gilbert, Cytotoxic cells induced in vitro by Epstein-Barr virus antigens. Cell. Immunol. 63: 91 (1981).CrossRefGoogle Scholar
  10. 10.
    C.H.H. Ten Napel, and T.H. The, Lymphocyte reactivity in infectious mononucleosis. J. Inf. Bis. 141s 716 (1980).Google Scholar
  11. 11.
    R. Szigeti, L. Timâr, and T. Révész, Leukocyte migration inhibition with Epstein-Barr virus negative and positive cell extracts. Allergy 35: 97 (1980).CrossRefGoogle Scholar
  12. 12.
    A. Poros, and E. Klein, Cultivation with K562 cells leads to blastogenesis and increased cytotoxicity with changed properties of the active cells when compared to fresh lymphocytes. Cell. Immunol. 41s 240 (1978).CrossRefGoogle Scholar
  13. 13.
    B.P. Haynes, R.T. Schooley, J.E. Grouse, C.R. Payling-Wright, R. Dolin, and A.S. Fauci, Characterization of thymus-derived lymphocyte subsets in acute Epstein-Barr virus-induced infectious mononucleosis. J. Immunol. 122: 699 (1979).Google Scholar
  14. 14.
    I.M. Zarling, and P.C. Kung, Monoclonal antibodies which distinguish between human NK cells and cytotoxic T lymphocytes. Nature 288: 394 (1980).CrossRefGoogle Scholar
  15. 15.
    E. Svedmyr, and M. Jondal, Cytotoxic effector cells specific for B-cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc. Natl. Acad, Sci. USA 72: 1622 (1975).CrossRefGoogle Scholar
  16. 16.
    M.G. Masucci, E. Klein, and S. Argov, Disappearance of the NK effect after ex-plantation of lymphocytes and generation of similar non-specific cytotoxicity correlated to the level of blastogenesis in activated cultures. J. Immunol. 124: 2458 (1980).Google Scholar
  17. 17.
    M.G. Masucci, G. Masucci, E. Klein, and W. Berthold, Target selectivity of interferon-induced human killer lymphocyte related to their Fc receptor expression. Proc. Natl. Acad. Sci. 77: 3620 (1980).CrossRefGoogle Scholar
  18. 18.
    E. Klein, I. Ernberg, M.G. Masucci, R. Szigeti, Y.T. Wu, G. Masucci, and E. Svedmyr, The role of T cell response to B cells and EBV antigens in control of EBV infected B cells in infectious mononucleosis. Cancer Res., in press.Google Scholar
  19. 19.
    E. Klein, M.G. Masucci, W. Berthold, and B.A. Blazar, Lymphocyte-mediated cytotoxicity toward virus-induced tumor cells; natural and activated killer lymphocytes in man. Cold Spring Harbor Conferences on Cell Proliferation, Cold Spring Harbor, USA 7: 1187 (1980).Google Scholar
  20. 20.
    E. Klein, Natural and activated cytotoxic T lymphocytes. Immunology Today 1: IV (1980).Google Scholar
  21. 21.
    E. Svedmyr, M. Jondal, W. Henle, O. Weiland, L. Rombo, and G. Klein, EBV specific killer cells and serological responses after onset of infectious mononucleosis. J. Clin. Lab. Immunol. 1: 225 (1978).Google Scholar
  22. 22.
    L. van der Waal, Epstein-Barr virus selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigens. J. Immunol. 127: 293 (1981).Google Scholar
  23. 23.
    E. Svedmyr, I. Ernberg, J. Seeley, O. Weiland, G. Masucci, K. Tsukuda, R. Szigeti, M.G. Masucci, H. Blomgren, W. Henle, and G. Klein, Virologie, immunologic and clinical observations on a patient during the incubation acute and convalescent phases of infectious mononucleosis. To be published.Google Scholar
  24. 24.
    I.S. Misko, B.J. Moss, and J.H. Pope, HLA-antigen-related restriction of T-lymphocyte cytotoxicity to Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 77: 1247 (1980).CrossRefGoogle Scholar
  25. 25.
    G. Tosato, I. Magrath, I. Koski, M. Booley, and M. Blease, Activation of suppressor T cells during Epstein-Barr virus induced infectious mononucleosis. New Engl. J. Med. 301: 1133 (1979).CrossRefGoogle Scholar
  26. 26.
    A.B. Rickinson, B. Crawford, and M.A. Epstein, Inhibition of the in vitro outgrowth of Epstein-Barr virus-transformed lymphocytes by thymus-dependent lymphocytes from infectious mononucleosis patients. Clin. Exp. Immunol. 28: 72 (1977).Google Scholar
  27. 27.
    B.A. Thorley-Lawson, L. Chess, and J. Strominger, Suppression of in vitro Epstein-Barr virus infection. J. Exp. Med.. 146: 495 (1977).CrossRefGoogle Scholar
  28. 28.
    A.G. Bird, S.M. McLachlan, and S. Britton, Cyclosporin promotes the spontaneous outgrowth in vitro of Epstein- Barr virus induced B-cell lines. Nature 289: 300 (1981).CrossRefGoogle Scholar
  29. 29.
    T.C. Shope, and J. Kaplan, Inhibition of the in vitro outgrowth of Epstein-Barr virus-infected lymphocytes by T lymphocytes. J. Immunol. 123: 2150 (1979).Google Scholar
  30. 30.
    D.A. Thorley-Lawson, The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell. J. Immunol. 124: 745 (1980).Google Scholar
  31. 31.
    D.J. Moss, A.B. Rickinson, and J.H. Pope, Long term T cell mediated immunity to Epstein Barr virus in man. III. Activation of cytotoxic cells in virus infected leukocyte cultures. Int. J. Cancer 23: 618 (1979).CrossRefGoogle Scholar
  32. 32.
    M.E. Weksler, and R. Kozak, Lymphocyte transformation induced by autologous cells. V. Generation of immunologic memory and specificity during the autologous mixed lymphocyte reaction. J. Exp. Med. 146: 1833 (1977).CrossRefGoogle Scholar
  33. 33.
    R.S. Chang, and Y.Y. Chang, Activation of lymphocytes from Epstein-Barr virus seronegative donors by autologous Epstein-Barr virus transformed cells. J. Infect. Bis. 142: 156 (1980).CrossRefGoogle Scholar
  34. 34.
    H. Spits, J. E. de Vries, and C. Terhorst, A permanent human cytotoxic T-cell line with high killing capacity against a lymphoblastoid B-cell line shows preference for HLA A, B target antigens and lacks spontaneous cytotoxic activity. Cell. Immunol. 59: 435 (1981).CrossRefGoogle Scholar
  35. 35.
    L.E. Wallace, A.B. Rickinson, M. Rowe, D.J. Moss, D.J. Allen, and M.A. Epstein, Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus transformed cell line. I. Virus specific arid non-specific components of the cytotoxic response. In press.Google Scholar
  36. 36.
    Y. Tanaka, K. Sugamura, Y. Hinuma, H. Sato, and K. Okochi, Memory of Epstein-Barr virus specific cytotoxic T cells in normal seropositive adults as revealed by an in vitro restimulation method. J. Immunol. 1 25: 1426 (1980).Google Scholar
  37. 37.
    M.G. Masucci, R. Szigeti, I. Ernberg, G. Masucci, G. Klein, J. Pritchard, C. Sieff, S. Lie, A. Glomstein, L. Businco, W. Henle, G. Henle, G. Pearson, K. Sakamoto, and D. Purtilo, Cellular immune defects to Epstein-Barr virus determined antigens in males with chronic mononucleosis. Cancer Res. in press.Google Scholar
  38. 38.
    G. Klein, Changes in gene dosage and gene expression: a common denominator in the tumorigenic action of viral oncogenes and non-random chromosomal changes? Nature, in press.Google Scholar
  39. 39.
    M. Jondal, C. Spina, and S. Targan, Human spontaneous killer cells selective for tumor-derived target cells. Nature 72: 62 (1978).CrossRefGoogle Scholar
  40. 40.
    E. Klein, Effect of immunization on the spread of transplanted lymphoma cells. J. Natl. Cancer Inst. 51: 1991 (1973).Google Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • Eva Klein
    • 1
  • George Klein
    • 1
  1. 1.Department of Tumor BiologyKarolinska InstitutetStockholmSweden

Personalised recommendations